We are live on ! Find out more
SGAM

Smith Group Asset Management Portfolio holdings

AUM $2.46B
1-Year Est. Return 57.16%
This Fund
S&P 500
This Quarter Est. Return
+7.19%
1 Year Est. Return
+57.16%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$3.41B
AUM Growth
+$62.9M
Cap. Flow
-$51.7M
Cap. Flow %
-1.51%
Top 10 Hldgs %
24.31%
Holding
517
New
48
Increased
183
Reduced
127
Closed
66

Top Sells

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$72.9M
2
CHRW icon
C.H. Robinson
CHRW
+$68M
3
CNC icon
Centene
CNC
+$47.2M
4
VC icon
Visteon
VC
+$40.3M
5
FDS icon
Factset
FDS
+$37.9M

Sector Composition

Rank Sector Weight
1 Technology 17.28%
2 Consumer Discretionary 16.74%
3 Healthcare 15.76%
4 Communication Services 11.95%
5 Industrials 11.43%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AVDL
201
DELISTED
Avadel Pharmaceuticals
AVDL
$377K 0.01%
30,430
+650
+2% +$8.49K
EXEL icon
202
Exelixis
EXEL
$13.1B
$376K 0.01%
29,410
RDUS
203
DELISTED
Radius Health, Inc.
RDUS
$376K 0.01%
6,950
AROW icon
204
Arrow Financial
AROW
$644M
$374K 0.01%
13,996
+277
+2% +$7.01K
PBYI icon
205
Puma Biotechnology
PBYI
$442M
$371K 0.01%
+5,540
New +$280K
EXAS
206
DELISTED
Exact Sciences
EXAS
$359K 0.01%
19,340
BELFB
207
Bel Fuse Inc Class B
BELFB
$4.1B
$354K 0.01%
+14,670
New +$313K
ALDR
208
DELISTED
Alder Biopharmaceuticals
ALDR
$353K 0.01%
10,760
-20
-0.2% -$609
ARC
209
DELISTED
ARC Document Solutions, Inc.
ARC
$350K 0.01%
93,520
+1,770
+2% +$6.41K
VNDA icon
210
Vanda Pharmaceuticals
VNDA
$304M
$348K 0.01%
+20,930
New +$282K
HALO icon
211
Halozyme
HALO
$12.2B
$341K 0.01%
28,200
NTES icon
212
NetEase
NTES
$85.4B
$340K 0.01%
7,065
AGX icon
213
Argan
AGX
$8.15B
$335K 0.01%
5,660
-3,880
-41% -$190K
APEI icon
214
American Public Education
APEI
$869M
$330K 0.01%
16,680
+310
+2% +$7.51K
ISEE
215
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
$311K 0.01%
6,740
+1,810
+37% +$102K
ANIK icon
216
Anika Therapeutics
ANIK
$277M
$309K 0.01%
6,460
+130
+2% +$6.42K
GTS
217
DELISTED
Triple-S Management Corporation
GTS
$307K 0.01%
14,726
+294
+2% +$6.58K
MYGN icon
218
Myriad Genetics
MYGN
$311M
$298K 0.01%
14,500
ANW
219
DELISTED
Aegean Marine Petroleum Network
ANW
$297K 0.01%
29,670
+590
+2% +$4.91K
HALL
220
DELISTED
Hallmark Financial Services, Inc.
HALL
$281K 0.01%
2,735
-62
-2% -$6.63K
CTBI icon
221
Community Trust Bancorp
CTBI
$1.41B
$273K 0.01%
7,360
-530
-7% -$19.1K
RUTH
222
DELISTED
Ruth's Hospitality Group, Inc.
RUTH
$272K 0.01%
19,290
-480
-2% -$7.34K
RYZ
223
Ryerson Holding Corp
RYZ
$1.45B
$269K 0.01%
23,790
+1,090
+5% +$14.7K
MOV icon
224
Movado Group
MOV
$817M
$268K 0.01%
12,490
+250
+2% +$5.6K
ACIC icon
225
American Coastal Insurance
ACIC
$470M
$261K 0.01%
+15,380
New +$244K

Similar funds

Smith Group Asset Management's Q3 2016 Portfolio in Review

As of Q3 2016, Smith Group Asset Management held 517 positions worth $3.41B, up 1.9% from $3.35B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Smith Group Asset Management's Q3 2016 filing shows 48 new, 183 increased, 127 reduced and 66 closed positions. Its largest new stake was Nordstrom: 1,213,747 shares worth $63M. The largest sale was Bristol-Myers Squibb, an estimated $72.9M.

By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 13% a quarter earlier, followed by Consumer Discretionary and Healthcare.

  • Smith Group Asset Management's largest Q3 2016 buy was Nordstrom: 1,213,747 shares worth $63M.
  • Smith Group Asset Management added most to Alphabet (Google) Class A in Q3 2016, an estimated $48.4M increase.
  • Smith Group Asset Management's biggest Q3 2016 reduction was Centene, cutting an estimated $47.2M.
  • Smith Group Asset Management fully exited Bristol-Myers Squibb in Q3 2016, selling an estimated $72.9M.
  • Smith Group Asset Management's ten largest holdings make up 24% of its $3.41B portfolio in Q3 2016.
  • Smith Group Asset Management opened 48 new positions and closed 66 in Q3 2016.
  • Smith Group Asset Management's portfolio value rose 1.9% quarter-over-quarter to $3.41B.

Based on Smith Group Asset Management's 13F filing for Q3 2016, filed 2 Nov 2016.